-
1دورية أكاديمية
المؤلفون: You Nie, Dandan Liu, Wen Yang, Yazhuo Li, Lihua Zhang, Xia Cheng, Ruyu Chen, Bingbing Yuan, Guangzheng Zhang, Hongwei Wang
المصدر: Virology Journal, Vol 19, Iss 1, Pp 1-12 (2022)
مصطلحات موضوعية: Cervical intraepithelial neoplasia, Human papillomavirus 16, Natural killer cell, Cytokines, TIGIT-PVR, KLRG1-Cadherin, Infectious and parasitic diseases, RC109-216
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1743-422XTest
-
2دورية أكاديمية
المؤلفون: Xiaowen Zhou, Jiangfeng Du, Xiuman Zhou, Xiaoshuang Niu, Wanqiong Li, Chunxia Chen, Sifan Lv, Aijun Wu, Shanshan Gou, Yixuan Sun, Wenjie Zhai, Lu Qiu, Yuanming Qi, Wenshan Zhao, Yanfeng Gao
المصدر: Cell Communication and Signaling, Vol 19, Iss 1, Pp 1-13 (2021)
مصطلحات موضوعية: Cancer immunotherapy, TIGIT/PVR, Molecular dynamics, Mutagenesis, Drug design, Medicine, Cytology, QH573-671
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1478-811XTest
-
3مؤتمر
المؤلفون: Xiaowen Zhou (2089552), Jiangfeng Du (1627135), Xiuman Zhou (4375900), Xiaoshuang Niu (10115943), Wanqiong Li (8783873), Chunxia Chen (134627), Sifan Lv (10115946), Aijun Wu (9381851), Shanshan Gou (6372980), Yixuan Sun (503279), Wenjie Zhai (5350622), Lu Qiu (640678), Yuanming Qi (5350616), Wenshan Zhao (4354984), Yanfeng Gao (9350817)
مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Microbiology, Genetics, Molecular Biology, Pharmacology, Immunology, Cancer, Plant Biology, Virology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, Cancer immunotherapy, TIGIT/PVR, Molecular dynamics, Mutagenesis, Drug design
-
4دورية أكاديمية
المؤلفون: Xiuman Zhou, Ling Jiao, Yuzhen Qian, Qingyu Dong, Yixuan Sun, Wei V. Zheng, Wenshan Zhao, Wenjie Zhai, Lu Qiu, Yahong Wu, Hongfei Wang, Yanfeng Gao, Junhui Chen
المصدر: Biomolecules; Volume 11; Issue 5; Pages: 706
مصطلحات موضوعية: CD47/SIRPα, TIGIT/PVR, drug-repositioning, small molecule inhibitor, azelnidipine, cancer immunotherapy
جغرافية الموضوع: agris
وصف الملف: application/pdf
العلاقة: Molecular Medicine; https://dx.doi.org/10.3390/biom11050706Test
-
5
المؤلفون: Yahong Wu, Wei V Zheng, Junhui Chen, Ling Jiao, Wenshan Zhao, Lu Qiu, Yixuan Sun, Yuzhen Qian, Xiuman Zhou, Wenjie Zhai, Hongfei Wang, Qingyu Dong, Yanfeng Gao
المصدر: Biomolecules, Vol 11, Iss 706, p 706 (2021)
Biomolecules
Volume 11
Issue 5مصطلحات موضوعية: 0301 basic medicine, Dihydropyridines, T-Lymphocytes, medicine.medical_treatment, Azelnidipine, CD47/SIRPα, Biochemistry, Mice, azelnidipine, 0302 clinical medicine, Cancer immunotherapy, Cricetinae, Neoplasms, Molecular Targeted Therapy, Receptors, Immunologic, Mice, Inbred BALB C, medicine.diagnostic_test, Chemistry, small molecule inhibitor, Calcium Channel Blockers, Acquired immune system, QR1-502, Gene Expression Regulation, Neoplastic, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Receptors, Virus, Immunotherapy, Azetidinecarboxylic Acid, medicine.drug, T cell, CD47 Antigen, Microbiology, Article, Flow cytometry, 03 medical and health sciences, Immune system, TIGIT, Cell Line, Tumor, medicine, Animals, Humans, Molecular Biology, cancer immunotherapy, CD47, Drug Repositioning, drug-repositioning, Immunity, Innate, Mice, Inbred C57BL, Disease Models, Animal, TIGIT/PVR, 030104 developmental biology, Cancer research
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f808e2d4b7840ac3abfb5d2a55d17120Test
https://www.mdpi.com/2218-273X/11/5/706Test -
6
المؤلفون: Wenshan Zhao, Wanqiong Li, Yanfeng Gao, Yuanming Qi, Chunxia Chen, Xiuman Zhou, Shanshan Gou, Lu Qiu, Wenjie Zhai, Jiangfeng Du, Yixuan Sun, Xiaowen Zhou, Sifan Lv, Xiaoshuang Niu, Aijun Wu
المصدر: Cell Communication and Signaling, Vol 19, Iss 1, Pp 1-13 (2021)
Cell Communication and Signaling : CCSمصطلحات موضوعية: T cell, Mutant, lcsh:Medicine, Cancer immunotherapy, CHO Cells, Molecular Dynamics Simulation, Molecular dynamics, Biochemistry, Jurkat cells, Drug design, Jurkat Cells, 03 medical and health sciences, Cricetulus, 0302 clinical medicine, TIGIT, medicine, Animals, Humans, Receptors, Immunologic, lcsh:QH573-671, Receptor, Molecular Biology, 030304 developmental biology, 0303 health sciences, lcsh:Cytology, Chemistry, Research, lcsh:R, Wild type, Cell Biology, Ligand (biochemistry), Coculture Techniques, eye diseases, Immune checkpoint, Cell biology, TIGIT/PVR, HEK293 Cells, medicine.anatomical_structure, Mutagenesis, 030220 oncology & carcinogenesis, Mutation, Computer-Aided Design, Receptors, Virus, sense organs, Protein Binding
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd60c86c4f04cc6c3fa7a02ca67d39b9Test
https://doi.org/10.1186/s12964-020-00701-yTest -
7دورية أكاديمية
المؤلفون: Zhou, Xiuman, Jiao, Ling, Qian, Yuzhen, Dong, Qingyu, Sun, Yixuan, Zheng, Wei V., Zhao, Weishan, Zhai, Weijie, Qiu, Lu, Wu, Yahong, Wang, Hongfei, Gao, Yanfeng, Chen, Junhui
مصطلحات موضوعية: Azelnidipine, Cancer immunotherapy, CD47/SIRPα, Drug-repositioning, Small molecule inhibitor, TIGIT/PVR
العلاقة: https://repository.hkust.edu.hk/ir/Record/1783.1-110873Test; Biomolecules, v. 11, (5), May 2021, article number 706; https://doi.org/10.3390/biom11050706Test; http://lbdiscover.ust.hk/uresolver?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rfr_id=info:sid/HKUST:SPI&rft.genre=article&rft.issn=2218-273X&rft.volume=11&rft.issueTest=(5)&rft.date=2021&rft.spage=&rft.aulast=Zhou&rft.aufirst=&rft.atitle=Repositioning+azelnidipine+as+a+dual+inhibitor+targeting+cd47%2Fsirp%CE%B1+and+tigit%2Fpvr+pathways+for+cancer+immuno-therapy&rft.title=Biomolecules; http://www.scopus.com/record/display.url?eid=2-s2.0-85105540480&origin=inwardTest; http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=LinksAMR&SrcApp=PARTNER_APP&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000653405100001Test
الإتاحة: https://doi.org/10.3390/biom11050706Test
https://repository.hkust.edu.hk/ir/Record/1783.1-110873Test
http://lbdiscover.ust.hk/uresolver?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rfr_id=info:sid/HKUST:SPI&rft.genre=article&rft.issn=2218-273X&rft.volume=11&rft.issueTest=(5)&rft.date=2021&rft.spage=&rft.aulast=Zhou&rft.aufirst=&rft.atitle=Repositioning+azelnidipine+as+a+dual+inhibitor+targeting+cd47%2Fsirp%CE%B1+and+tigit%2Fpvr+pathways+for+cancer+immuno-therapy&rft.title=Biomolecules
http://www.scopus.com/record/display.url?eid=2-s2.0-85105540480&origin=inwardTest
http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=LinksAMR&SrcApp=PARTNER_APP&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000653405100001Test -
8مورد إلكتروني
مصطلحات الفهرس: Azelnidipine, Cancer immunotherapy, CD47/SIRPα, Drug-repositioning, Small molecule inhibitor, TIGIT/PVR, Article
URL:
http://repository.ust.hk/ir/Record/1783.1-110873Test http://lbdiscover.ust.hk/uresolver?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rfr_id=info:sid/HKUST:SPI&rft.genre=article&rft.issn=2218-273X&rft.volume=11&rft.issueTest=(5)&rft.date=2021&rft.spage=&rft.aulast=Zhou&rft.aufirst=&rft.atitle=Repositioning+azelnidipine+as+a+dual+inhibitor+targeting+cd47%2Fsirp%CE%B1+and+tigit%2Fpvr+pathways+for+cancer+immuno-therapy&rft.title=Biomolecules http://www.scopus.com/record/display.url?eid=2-s2.0-85105540480&origin=inwardTest http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=LinksAMR&SrcApp=PARTNER_APP&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000653405100001Test